(MedPage Today) -- In this exclusive video report, Kenneth W. Mahaffey, MD, of the Duke Clinical Research Institute reviews aspects of the pivotal trials of the new class of oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation with cardiology editor Chris Kaiser.
Júlio Leonardo B. Pereira
No comments:
Post a Comment